Backed by big medtech including Medtronic, MD Start aims not just to incubate start-ups but to create new device companies from scratch.
A tiny Israeli company has beaten some of the biggest medtechs in the world to the wireless charging of heart pumps.
The battle for dominance of the transcatheter aortic valve market has shifted to new territory. And once again, Edwards Lifesciences is winning.
A positive readout for Medtronic's Tyrx envelope could mean an extra $1,000 per cardiac implant in the company's pocket.
Transcatheter mitral valve replacement is wrenching the spotlight away from the repair devices that grabbed the headlines last summer.
Despite encouraging interim pivotal data, Carmat’s artificial heart seems as far from market as ever.
The immensely complex and long-running intertwined litigation between the two medtechs has been brought to an end.
Mainstay Medical still hopes for US approval of its Reactiv8 device for chronic back pain despite trial failure.
The world’s first non-implanted vagus nerve stimulator is becoming established as a therapy for headache and migraine. But a move into autoimmune conditions will require…